Migraine is a common primary headache disorder characterized by recurrent attacks of moderate to severe headache often accompanied by nausea, photophobia, and phonophobia. It contributes substantially to disability worldwide.
AbbVie raised 2026 revenue and EPS guidance after first-quarter results beat estimates, with Skyrizi and Rinvoq driving growth. Humira erosion continued as neuroscience, oncology and pipeline assets supported the outlook.
Eli Lilly, AbbVie, Vertex, Gilead Sciences and Pfizer were identified as pharmaceutical stocks to watch, with Abbott Laboratories and McKesson appearing on a separate seven-stock list.
Novartis is emphasizing innovative medicines across oncology, immunology, neuroscience and gene therapy. The company targets mid-single-digit sales growth through 2027 and core operating income margins above 35%.
The FDA has announced plans to crack down on active pharmaceutical ingredients used in compounded GLP-1 drugs and warned about the risks of these products. The agency has cited counterfeit products, non-FDA-approved ingredients and more than 1,000 adverse event reports tied to compounded semaglutide and tirzepatide.
AbbVie projects 43-45% earnings growth in 2026 as newer immunology drugs Skyrizi and Rinvoq offset declining Humira sales, while maintaining its 54-year dividend increase streak as a Dividend King.
Lundbeck's investigational anti-PACAP antibody bocunebart demonstrated statistically significant reduction in monthly migraine days versus placebo in a phase IIb trial of patients who had failed prior preventive treatments, positioning the company for phase III discussions with regulators.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07598045 |
Efficacy of Anti-IL-6 Treatments on Migraine in Patients Treated With Anti-IL-6 for a Rheumatological Condition |
NOT_YET_RECRUITING | |
| NCT07594769 |
A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults |
NOT_YET_RECRUITING | PHASE1 |
| NCT07593287 |
PEDİATRİC MİGRAİNE PATİENTS İN FİNDİNGS |
COMPLETED | |
| NCT07579481 |
Vortioxetine in Depression and Concomitant Migraine |
RECRUITING | |
| NCT07577050 |
A Phase II Study of NB001 for Acute Migraine Treatment |
NOT_YET_RECRUITING | PHASE2 |
| NCT07573488 |
Sleep, Stress and Migraine - an Observational and Training Study |
RECRUITING | NA |
| NCT07567300 |
Common Pain Mechanisms in Migraine, Migraine-Related Neck Pain, and Lower Back Pain: A Cross Sectional Study |
RECRUITING | |
| NCT07559565 |
Migraine is Associated With Altered Mechanical Pain Sensitivity. This Study Investigates Mechanical Pain Sensitivity, Headache Burden, and Quality of Life in Episodic and Chronic Migraine, Comparing Pressure Algometry and Algopeg® and Assessing Mechanosensitivity of Peripheral Nerves. |
NOT_YET_RECRUITING | |
| NCT07554664 |
Central Sensitization, Work-Related Stress, and Musculoskeletal Symptoms in Desk-Based Workers With and Without Migraine |
RECRUITING | |
| NCT07546201 |
Investigation of Imagery Abilities in Individuals With Migraine |
NOT_YET_RECRUITING |
